Form 4: Verastem CEO Sells Shares to Cover Tax Obligations from RSU Vesting

Verastem, Inc.'s President and CEO, Dan Paterson, reported the sale of 335 shares of common stock on June 16, 2025, at $5.65 per share, solely to satisfy statutory tax withholding requirements related to the vesting of restricted stock units.

Summary

• Dan Paterson, President and CEO, and a Director of Verastem, Inc. (VSTM), filed a Form 4, detailing a change in his beneficial ownership.
• The filing reports a transaction on June 16, 2025, where Mr. Paterson sold 335 shares of Verastem Common Stock.
• The shares were sold at a price of $5.65 per share, resulting in total proceeds of approximately $1,892.75.
• The sale was explicitly stated to be for the purpose of satisfying statutory withholding requirements in connection with the vesting of restricted stock units.
• Following this transaction, Mr. Paterson beneficially owns 461,647 shares of Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's a sale of shares by an insider, it's explicitly stated to be for tax withholding purposes related to RSU vesting, which is a routine and expected event, not indicative of a lack of confidence in the company.

Positives

• The sale was not a discretionary sale but rather a mandatory transaction to cover tax obligations arising from the vesting of restricted stock units, indicating a routine compensation event rather than a lack of confidence in the company.
• The vesting of restricted stock units represents a form of equity compensation for the CEO, aligning management's interests with shareholders.

Negatives

• The transaction resulted in a slight reduction of the CEO's direct beneficial ownership by 335 shares.

Risks

• No specific risks are detailed in this Form 4 filing beyond the inherent market risks associated with holding equity.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide broader industry context or trends. It reflects a standard executive compensation event within the biotechnology or pharmaceutical sector.

Comparison to Industry Standards

• This document is a standard insider transaction report (Form 4) for a U.S. publicly traded company.
• The sale of shares to cover tax obligations upon RSU vesting is a common practice among executives across various industries and is consistent with typical executive compensation structures involving equity awards.
• No specific comparable companies or projects are mentioned or implied within this filing.

Related Party Transactions

• The transaction involves the sale of shares by Dan Paterson, President and CEO, and a Director of Verastem, Inc., which is an insider transaction and falls under the purview of related party dealings due to his executive position.

Stakeholder Impact

• Shareholders: Minimal direct impact as the sale is small (335 shares) and for a routine tax purpose, not signaling a change in management's confidence.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• The document does not specify any future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

Verastem, VSTM, SEC Form 4, Insider Trading, Stock Sale, CEO, Restricted Stock Units, Tax Withholding, Corporate Governance, Executive Compensation